JNJ
Johnson & Johnson
NYSE · Healthcare · Drug Manufacturers - General · US
$276.58
−0.66%Forward multiples
Based on analyst estimates
- P/E forward
- 23.18x
- P/E 2026E
- 24.00x
- P/E 2027E
- 21.81x
- P/E 2028E
- 19.51x
- P/S forward
- 6.39x
Trailing multiples
Trailing twelve months
- P/E TTM
- 31.97x
- PEG TTM
- 0.85x
- Price / book
- 7.84x
- Price / sales
- 6.81x
- Price / cash flow
- 28.12x
Enterprise value
- Enterprise value
- $694.8B
- EV / sales
- 7.10x
- EV / EBITDA
- 20.60x
- EV / EBIT
- 26.46x
- Market cap
- $666.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026